HomeCompareCHYFF vs KMB

CHYFF vs KMB: Dividend Comparison 2026

CHYFF yields 8.11% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHYFF wins by $47.1K in total portfolio value
10 years
CHYFF
CHYFF
● Live price
8.11%
Share price
$14.63
Annual div
$1.19
5Y div CAGR
21%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$93.0K
Annual income
$20,198.62
Full CHYFF calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — CHYFF vs KMB

📍 CHYFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHYFFKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHYFF + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CHYFF pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHYFF
Annual income on $10K today (after 15% tax)
$689.20/yr
After 10yr DRIP, annual income (after tax)
$17,168.83/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, CHYFF beats the other by $12,729.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHYFF + KMB for your $10,000?

CHYFF: 50%KMB: 50%
100% KMB50/50100% CHYFF
Portfolio after 10yr
$69.5K
Annual income
$12,710.48/yr
Blended yield
18.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

CHYFF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.2
Piotroski
6/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHYFF buys
0
KMB buys
0
No recent congressional trades found for CHYFF or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHYFFKMB
Forward yield8.11%5.25%
Annual dividend / share$1.19$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR21%17%
Portfolio after 10y$93.0K$45.9K
Annual income after 10y$20,198.62$5,222.34
Total dividends collected$63.0K$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: CHYFF vs KMB ($10,000, DRIP)

YearCHYFF PortfolioCHYFF Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$11,681$981.10$11,314$614.45+$367.00CHYFF
2$13,795$1,295.98$12,867$760.19+$928.00CHYFF
3$16,491$1,730.74$14,713$945.27+$1.8KCHYFF
4$19,985$2,339.75$16,924$1,181.90+$3.1KCHYFF
5$24,591$3,206.49$19,596$1,486.64+$5.0KCHYFF
6$30,774$4,461.62$22,850$1,882.16+$7.9KCHYFF
7$39,242$6,313.97$26,849$2,399.80+$12.4KCHYFF
8$51,094$9,104.87$31,812$3,083.36+$19.3KCHYFF
9$68,076$13,405.81$38,033$3,994.72+$30.0KCHYFF
10$93,040$20,198.62$45,918$5,222.34+$47.1KCHYFF

CHYFF vs KMB: Complete Analysis 2026

CHYFFStock

Cathay Financial Holding Co Ltd is a financial holding company that primarily serves the Taiwan market. The scope of its business is limited by the operation of law to the investment and management of financial services enterprises. The company is a hub for financial services primarily in insurance and banking, and secondarily in asset management. Cathay Financial Holding emphasizes cross-selling and information technology integration in its business model. most of its insurance business, which constitutes approximately half of the company's revenue mix, is related to life insurance. Its banking business, which makes up nearly the other half of its business, is mostly related to consumer and corporate banking.

Full CHYFF Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this CHYFF vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHYFF vs SCHDCHYFF vs JEPICHYFF vs OCHYFF vs KOCHYFF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.